Drug Co. Investors Settle Clinical Trial Suit For $2.3M
Investors of biotherapeutics company Kiromic BioPharma Inc. asked a New York federal judge to initially approve a $2.3 million settlement in a suit accusing the company of touting prospects for two...To view the full article, register now.
Already a subscriber? Click here to view full article